Dennis Cirino - Jan 5, 2023 Form 4 Insider Report for SeaSpine Holdings Corp (SPNE)

Role: SVP, Global Spinal Systems
Signature: /s/ Paul Benny, Attorney-in-Fact for Dennis L. Cirino
Stock symbol: SPNE
Transactions as of: Jan 5, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/9/2023, 06:17 PM
Previous filing: Jan 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SPNE	Common Stock	Disposed to Issuer		-48.6K	-100%		0	Jan 5, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SPNE	Restricted Stock Units	Disposed to Issuer		-11.8K	-100%		0	Jan 5, 2023	Common Stock	11.8K		Direct	F2, F3, F4
transaction	SPNE	Restricted Stock Units	Disposed to Issuer		-16.5K	-100%		0	Jan 5, 2023	Common Stock	16.5K		Direct	F2, F5, F6
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-34.2K	-100%		0	Jan 5, 2023	Common Stock	34.2K	$18.24	Direct	F7, F8
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-53.5K	-100%		0	Jan 5, 2023	Common Stock	53.5K	$12.01	Direct	F9, F10
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-5.85K	-100%		0	Jan 5, 2023	Common Stock	5.85K	$9.93	Direct	F11, F12
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-19.7K	-100%		0	Jan 5, 2023	Common Stock	19.7K	$16.86	Direct	F13, F14
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-41.2K	-100%		0	Jan 5, 2023	Common Stock	41.2K	$12.67	Direct	F15, F16
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-20.6K	-100%		0	Jan 5, 2023	Common Stock	20.6K	$12.67	Direct	F15, F17

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Dennis Cirino is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 20,213 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2	Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.
F3	The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
F4	These restricted stock units were assumed by Orthofix in the merger and replaced by 4,914 Orthofix restricted stock units.
F5	The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
F6	These restricted stock units were assumed by Orthofix in the merger and replaced by 6,865 Orthofix restricted stock units.
F7	The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F8	This option was assumed by Orthofix in the merger and replaced with an option to purchase 14,242 shares of Orthofix at a price of $43.82 per share.
F9	The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F10	This option was assumed by Orthofix in the merger and replaced with an option to purchase 22,279 shares of Orthofix at a price of $28.85 per share.
F11	The option fully vested and became exercisable on June 21, 2020.
F12	This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,433 shares of Orthofix at a price of $23.86 per share.
F13	The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F14	This option was assumed by Orthofix in the merger and replaced with an option to purchase 8,181 shares of Orthofix at a price of $40.50 per share.
F15	The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F16	This option was assumed by Orthofix in the merger and replaced with an option to purchase 17,163 shares of Orthofix at a price of $30.44 per share.
F17	This option was assumed by Orthofix in the merger and replaced with an option to purchase 8,583 shares of Orthofix at a price of $36.04 per share.